Clinical Trials on Study hCG and Media in Singapore
Total 19 results
-
National University Hospital, SingaporeUnknownFocus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.Singapore
-
Yale-NUS CollegeCompletedFocus of Study is Patient Responses to an Obesity Management Questionnaire Administered by SGH Life CentreSingapore
-
Yale-NUS CollegeCompletedMental Health Wellness 1 | Mental Health Issue | Social Media Addiction | Internet Addiction | Mental Health Wellness 2Singapore
-
Singapore Clinical Research InstituteSingapore General Hospital; Duke-NUS Graduate Medical SchoolTerminatedAssess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.Singapore
-
Yale-NUS CollegeCompletedFocus of Study is Patient Responses to an Obesity Management Questionnaire Administered by SGH Life CentreSingapore
-
AO Clinical Investigation and Publishing DocumentationCompletedOrbital Floor Fracture | Medial Orbital Wall FractureSingapore, United States, Germany, Spain
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)Italy, Poland, Singapore, United States, China, Ukraine
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)China, Singapore
-
Bristol-Myers SquibbCompletedHepatocellular Carcinoma (HCC)France, Korea, Republic of, Taiwan, United States, Singapore, Philippines, Malaysia, Hong Kong
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Bristol-Myers SquibbWithdrawnHepatitis C Virus (HCV)India, Korea, Republic of, Poland, Taiwan, Spain, Canada, Russian Federation, Colombia, Singapore, Netherlands, Ireland, United Kingdom, Czech Republic, Hungary, Romania, Hong Kong, Turkey, United States, China, Egypt
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedHepatocellular Carcinoma (HCC)Italy, Korea, Republic of, Poland, United States, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Japan, Malaysia, Philippines, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Bristol-Myers SquibbCompletedHepatitis C Virus (HCV)Australia, Belgium, France, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Taiwan, United States, Chile, Hong Kong, Argentina, Netherlands, United Kingdom, Singapore, New Zealand, Finland, Greece
-
AbbVieCompletedHepatitis C Virus (HCV)China, Korea, Republic of, Singapore
-
SillaJen, Inc.CompletedHepatocellular Carcinoma (HCC)United States, Canada, New Zealand, Australia, China, France, Germany, Hong Kong, Israel, Italy, Korea, Republic of, Portugal, Singapore, Taiwan, Thailand, United Kingdom